HHS initiates new program to improve clinical trial efficiency

What happened

The U.S. Department of Health and Human Services has launched the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program to enhance the design of clinical trials. The initiative aims to expedite the process of drug development by soliciting innovative proposals from selected teams and promoting the use of automation and real-time data analysis.

Why it matters

This program could lead to faster and more cost-effective development of new medications, potentially benefiting patients and the healthcare system.

How this story affects people

How does this story affect you if you are a patient awaiting new treatments?

This program aims to expedite the development of new medications, potentially leading to faster access to innovative therapies. If successful, you may benefit from more effective treatments becoming available sooner.

How does this story affect you if you are involved in drug development or clinical research?

The SURPASS program could change the way clinical trials are designed, making the process more efficient and less costly. This initiative may provide new opportunities for collaboration and funding in the drug development landscape.

Want this written about you?

The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.

Get your Ripple